Abstract
Nocturia is a common symptom in the elderly and is associated with sleep fragmentation, irregular heartbeats, diabetes and stroke. It may be associated with obstructive sleep apnea-Hypopnea syndrome (OSAHS), and when present is seen more often in patients less than 50 years of age. OSAHS is often overlooked as a cause of nocturia, especially in the presence of coexisting diseases such as diabetes. OSAHS patients with frequent nocturia have higher body mass index (BMI), greater apnea-hypopnea index (AHI), and worse quality of life. Nocturia is correlated with the severity of OSAHS and the use of continuous positive airway pressure (CPAP) has shown to be beneficial. In this review, we discuss the various pathophysiologic mechanisms, clinical features and treatment options for patients with nocturia and obstructive sleep apnea-Hypopnea Syndrome.
Keywords: Aldostorone, atrial natriuretic peptide, BIPAP, CPAP, nocturia, obstructive sleep apnea-hypopnea syndrome, sympathetic surge.
Current Respiratory Medicine Reviews
Title:Nocturia in Obstructive Sleep Apnea-Hypopnea Syndrome: An Underappreciated Symptom
Volume: 9 Issue: 3
Author(s): Guy Aristide, Michael Weinstein and Girish B. Nair
Affiliation:
Keywords: Aldostorone, atrial natriuretic peptide, BIPAP, CPAP, nocturia, obstructive sleep apnea-hypopnea syndrome, sympathetic surge.
Abstract: Nocturia is a common symptom in the elderly and is associated with sleep fragmentation, irregular heartbeats, diabetes and stroke. It may be associated with obstructive sleep apnea-Hypopnea syndrome (OSAHS), and when present is seen more often in patients less than 50 years of age. OSAHS is often overlooked as a cause of nocturia, especially in the presence of coexisting diseases such as diabetes. OSAHS patients with frequent nocturia have higher body mass index (BMI), greater apnea-hypopnea index (AHI), and worse quality of life. Nocturia is correlated with the severity of OSAHS and the use of continuous positive airway pressure (CPAP) has shown to be beneficial. In this review, we discuss the various pathophysiologic mechanisms, clinical features and treatment options for patients with nocturia and obstructive sleep apnea-Hypopnea Syndrome.
Export Options
About this article
Cite this article as:
Aristide Guy, Weinstein Michael and Nair B. Girish, Nocturia in Obstructive Sleep Apnea-Hypopnea Syndrome: An Underappreciated Symptom, Current Respiratory Medicine Reviews 2013; 9 (3) . https://dx.doi.org/10.2174/1573398X113099990019
DOI https://dx.doi.org/10.2174/1573398X113099990019 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Adrenomedullin and Oxidative Stress in Vascular Damage and Metabolic Disease
Current Hypertension Reviews TiO2-Nanowired Delivery of Mesenchymal Stem Cells Thwarts Diabetes- Induced Exacerbation of Brain Pathology in Heat Stroke: An Experimental Study in the Rat Using Morphological and Biochemical Approaches
CNS & Neurological Disorders - Drug Targets Isolation and Purification of Kudinosides from Kuding Tea by Semi-Preparative HPLC Combined with MCI-GEL Resin
Current Analytical Chemistry HPLC-DAD-Q-TOF/MS-Based Screening and Analysis of the Multiple Absorbed Bioactive Components in Rat Serum after Oral Administration of Xiexin Tang
Current Pharmaceutical Analysis Targeting TNF-Alpha to Elucidate and Ameliorate Neuroinflammation in Neurodegenerative Diseases
CNS & Neurological Disorders - Drug Targets Advances in the Treatment of Neurodegenerative Disorders Employing Nanoparticles
Recent Patents on Drug Delivery & Formulation Use of Push-Pull Superfusion Technique for Identifying Neurotransmitters Involved in Brain Functions: Achievements and Perspectives
Current Neuropharmacology Seeds as a Production System for Molecular Pharming Applications: Status and Prospects
Current Pharmaceutical Design The Pharmacological Effects of Novokinin; a Designed Peptide Agonist of the Angiotensin AT<sab>2</sab> Receptor
Current Pharmaceutical Design Magnesium and Anaesthesia
Current Drug Targets Antipsychotic Polypharmacy
Current Pharmaceutical Design The Use of Antiparkinsonian Agents in the Management of Drug-Induced Extrapyramidal Symptoms
Current Pharmaceutical Design Therapeutic Prospects for Parathyroid Hormone and Parathyroid Hormone Analogs
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Pharmacological Management of Type 2 Diabetes Mellitus: An Update
Current Diabetes Reviews Use of N-acetyl-cysteine to Prevent Nephrotoxicity Associated with Iodinated Contrast Agents
Current Drug Therapy Comparing the Efficacy and Safety of Dexmedetomidine/Ketamine with Propofol/Fentanyl for Sedation in Colonoscopy Patients: A Doubleblinded Randomized Clinical Trial
CNS & Neurological Disorders - Drug Targets Are the Antioxidant Properties of Carvedilol Important for the Protection of Cardiac Mitochondria?
Current Vascular Pharmacology Should STEMI Patients Receive Opiate Analgesia? The Morphine Paradox
Current Vascular Pharmacology Anti-Oxidant Gene Therapy by NFkB Decoy Oligodeoxynucleotide
Current Pharmaceutical Biotechnology Structural Modeling Studies of Aldehyde Dehydrogenase X: Insights into Key Interactions in the Tetrameric Assembly of the Isoenzyme
Protein & Peptide Letters